Markowitz, Lauri E <br/><br/>
Two vs Three Doses of Human Papillomavirus Vaccine: New Policy for the Second Decade of the Vaccination Program.  [electronic resource] 

 -  JAMA  12 2016 
 - 2370-2372 p.  digital 
<br/><br/> Publication Type: Editorial 
<br/><br/><label>ISSN: </label>1538-3598 
<br/><br/><label>Standard No.: </label>10.1001/jama.2016.16393  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Advisory Committees<br/>Age Factors<br/>Antibodies, Viral--blood<br/>Centers for Disease Control and Prevention, U.S.<br/>Child<br/>Drug Approval<br/>Female<br/>Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18--immunology<br/>Humans<br/>Immunization Programs<br/>Immunization Schedule<br/>Male<br/>Papillomavirus Vaccines--administration & dosage<br/>United States<br/>United States Food and Drug Administration<br/>Young Adult